| This article has been cited by |
| 1 | Terminalia catappa leaf extracts inhibited metastasis of A2058 and A375 melanoma cells via downregulating p-Src and ß-catenin pathway in vitro | |
| Chin-Kuo Chang,Shu-Chen Chu,Jing-Yang Huang,Pei-Ni Chen,Yih-Shou Hsieh |
| Frontiers in Pharmacology.2022;13() |
| [DOI] |
|
| 2 | Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications | |
| Tapan Behl,Anita Kotwani |
| Journal of Pharmacy and Pharmacology.2017;69(2)123 |
| [DOI] |
|
| 3 | Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp. | |
| Analucia G. Terças,Andrea de Souza Monteiro,Eduardo B. Moffa,Julliana R. A. dos Santos,Eduardo M. de Sousa,Anna R. B. Pinto,Paola C. da Silva Costa,Antonio C. R. Borges,Luce M. B. Torres,Allan K. D. Barros Filho,Elizabeth S. Fernandes,Cristina de Andrade Monteiro |
| Frontiers in Microbiology.2017;8(2)123 |
| [DOI] |
|
| 4 | Terminalia catappa, an anticlastogenic agent against MMS induced genotoxicity in the human lymphocyte culture and in bone marrow cells of Albino mice | |
| Mohammad Sultan Ahmad,Sheeba Ahmad,M. Arshad,K.B. Rai,Mohammad Afzal |
| Egyptian Journal of Medical Human Genetics.2014;15(3)227 |
| [DOI] |
|
